
What is The Mechanism of Action of Dalpiciclib (Airuikang)? Targeting the CDK4/6 Pathway in HR-Positive Breast Cancer
For patients diagnosed with HR-positive, HER2-negative breast cancer, treatment is often not a single drug…

For patients diagnosed with HR-positive, HER2-negative breast cancer, treatment is often not a single drug…

Pulmonary hypertension (PH) is a progressive and potentially life-threatening condition characterized by persistently elevated pressure…

As innovation in drug research and development continues to accelerate, the pharmaceutical industry is entering…

In the era of precision oncology, an effective treatment strategy requires more than just a…

In China, chronic hepatitis B remains a major public health challenge, affecting tens of millions…

As global demographic shifts, evolving disease landscapes, and rising expectations for treatment experience continue to…

In the field of oncology, relapsed or refractory peripheral T-cell lymphoma (PTCL) and endocrine therapy…

The treatment of advanced gastrointestinal stromal tumors (GIST) is a long and arduous race against…

In the field of HIV antiviral therapy, “simplification” and “potency” have long been the two…

(China, December 23, 2025) — Sunshine Guojian Pharmaceutical, a leading biopharmaceutical company in China, today…